Evidence map›Paper›PMID 25874612›Full record

ArticlePloS one2015

MALDI-TOF mass spectrometry for the detection and differentiation of Entamoeba histolytica and Entamoeba dispar.

Adriana Calderaro, Maddalena Piergianni, Mirko Buttrini, Sara Montecchini, Giovanna Piccolo, Chiara Gorrini, Sabina Rossi, Carlo Chezzi, Maria Cristina Arcangeletti, Maria Cristina Medici and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. MALDI-TOF Mass Spectroscopy Applications in Clinical Microbiology.Advances in pharmacological and pharmaceutical sciences · 2021
    Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Detection and differentiation of Entamoeba histolytica and Entamoeba dispar in clinical samples through PCR-denaturing gradient gel electrophoresis.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2017
    Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Adriana CalderaroUnit of Microbiology and Virology, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.
Maddalena PiergianniUnit of Microbiology and Virology, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.
Mirko ButtriniUnit of Microbiology and Virology, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.
Sara MontecchiniUnit of Microbiology and Virology, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.
Giovanna PiccoloUnit of Microbiology and Virology, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.
Chiara GorriniUnit of Microbiology and Virology, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.
Sabina RossiUnit of Microbiology and Virology, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.
Carlo ChezziUnit of Microbiology and Virology, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.
Maria Cristina ArcangelettiUnit of Microbiology and Virology, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.
Maria Cristina MediciUnit of Microbiology and Virology, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.
Flora De ContoUnit of Microbiology and Virology, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.
University of Parma · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Detection of Entamoeba histolytica and its differentiation from Entamoeba dispar is an important goal of the clinical parasitology laboratory. The aim of this study was the identification and differentiation of E. histolytica and E. dispar by MALDI-TOF MS, in order to evaluate the application of this technique in routine diagnostic practice. MALDI-TOF MS was applied to 3 amebic reference strains and to 14 strains isolated from feces that had been differentiated by molecular methods in our laboratory. Protein extracts from cultures of these strains (axenic cultures for the 3 reference strains and monoxenic cultures for the 14 field isolates) were analyzed by MALDI-TOF MS and the spectra obtained were analyzed by statistical software. Five peaks discriminating between E. histolytica and E. dispar reference strains were found by protein profile analysis: 2 peaks (8,246 and 8,303 Da) specific for E. histolytica and 3 (4,714; 5,541; 8,207 Da) for E. dispar. All clinical isolates except one showed the discriminating peaks expected for the appropriate species. For 2 fecal samples from which 2 strains (1 E. histolytica and 1 E. dispar) out of the 14 included in this study were isolated, the same discriminating peaks found in the corresponding isolated amebic strains were detected after only 12h (E. histolytica) and 24h (E. dispar) of incubation of the fecal samples in Robinson's medium without serum. Our study shows that MALDI-TOF MS can be used to discriminate between E. histolytica and E. dispar using in vitro xenic cultures and it also could have potential for the detection of these species in clinical samples.

Indexed as

Chromatography, High Pressure LiquidDiagnosis, DifferentialElectrophoresis, Polyacrylamide GelEntamoebaEntamoeba histolyticaEntamoebiasisFecesHost-Parasite InteractionsHumansPolymerase Chain ReactionPrincipal Component AnalysisProteomeProteomicsProtozoan ProteinsRNA, Ribosomal, 18SROC CurveProteomeProtozoan ProteinsRNA, Ribosomal, 18S

Identifiers

PMID25874612
PMCPMC4398369
OpenAlexW2083523681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.